Heartseedの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/04/01 | 2,187 | 2,231 | 2,001 | 2,005 | -185 | -8.4% | 871,500 |
2025/03/31 | 2,236 | 2,303 | 2,166 | 2,190 | -35 | -1.6% | 699,800 |
2025/03/28 | 2,158 | 2,232 | 2,101 | 2,225 | +117 | +5.6% | 758,900 |
2025/03/27 | 2,130 | 2,195 | 2,053 | 2,108 | -61 | -2.8% | 833,500 |
2025/03/26 | 2,290 | 2,300 | 2,158 | 2,169 | -146 | -6.3% | 1,121,900 |
2025/03/25 | 2,400 | 2,406 | 2,280 | 2,315 | -35 | -1.5% | 884,200 |
2025/03/24 | 2,499 | 2,520 | 2,341 | 2,350 | +6 | +0.3% | 1,784,000 |
2025/03/21 | 2,156 | 2,398 | 2,156 | 2,344 | +190 | +8.8% | 1,941,500 |
2025/03/19 | 2,181 | 2,280 | 2,154 | 2,154 | -77 | -3.5% | 1,198,100 |
2025/03/18 | 2,301 | 2,455 | 2,207 | 2,231 | -91 | -3.9% | 3,239,000 |
2025/03/17 | 2,098 | 2,375 | 2,006 | 2,322 | +313 | +15.6% | 3,742,100 |
2025/03/14 | 1,820 | 2,145 | 1,819 | 2,009 | +254 | +14.5% | 4,097,700 |
2025/03/13 | 1,786 | 1,798 | 1,740 | 1,755 | -15 | -0.8% | 469,700 |
2025/03/12 | 1,760 | 1,781 | 1,731 | 1,770 | +20 | +1.1% | 438,600 |
2025/03/11 | 1,664 | 1,765 | 1,655 | 1,750 | +61 | +3.6% | 502,400 |
2025/03/10 | 1,670 | 1,759 | 1,660 | 1,689 | +30 | +1.8% | 553,400 |
2025/03/07 | 1,650 | 1,707 | 1,636 | 1,659 | -21 | -1.3% | 345,400 |
2025/03/06 | 1,681 | 1,708 | 1,669 | 1,680 | ±0 | ±0% | 247,600 |
2025/03/05 | 1,664 | 1,710 | 1,655 | 1,680 | -24 | -1.4% | 342,700 |
2025/03/04 | 1,782 | 1,790 | 1,689 | 1,704 | -118 | -6.5% | 680,300 |
2025/03/03 | 1,800 | 1,837 | 1,768 | 1,822 | +56 | +3.2% | 402,400 |
2025/02/28 | 1,805 | 1,836 | 1,734 | 1,766 | -74 | -4% | 445,000 |
2025/02/27 | 1,820 | 1,863 | 1,751 | 1,840 | +10 | +0.5% | 562,000 |
2025/02/26 | 1,856 | 1,868 | 1,798 | 1,830 | -29 | -1.6% | 393,200 |
2025/02/25 | 1,763 | 1,913 | 1,762 | 1,859 | +60 | +3.3% | 736,100 |
2025/02/21 | 1,824 | 1,831 | 1,773 | 1,799 | -56 | -3% | 595,400 |
2025/02/20 | 1,766 | 1,855 | 1,735 | 1,855 | +69 | +3.9% | 690,700 |
2025/02/19 | 1,867 | 1,877 | 1,770 | 1,786 | -81 | -4.3% | 866,200 |
2025/02/18 | 1,860 | 1,996 | 1,800 | 1,867 | +36 | +2% | 1,798,300 |
2025/02/17 | 1,800 | 1,947 | 1,766 | 1,831 | +65 | +3.7% | 1,727,800 |
2025/02/14 | 1,682 | 1,785 | 1,647 | 1,766 | +100 | +6% | 983,900 |
2025/02/13 | 1,617 | 1,710 | 1,610 | 1,666 | +89 | +5.6% | 1,002,200 |
2025/02/12 | 1,620 | 1,652 | 1,570 | 1,577 | -42 | -2.6% | 792,200 |
2025/02/10 | 1,629 | 1,673 | 1,606 | 1,619 | -9 | -0.6% | 586,400 |
2025/02/07 | 1,806 | 1,829 | 1,627 | 1,628 | -180 | -10% | 1,751,000 |
2025/02/06 | 1,657 | 1,808 | 1,655 | 1,808 | +162 | +9.8% | 1,820,500 |
2025/02/05 | 1,618 | 1,696 | 1,593 | 1,646 | -6 | -0.4% | 1,166,700 |
2025/02/04 | 1,730 | 1,769 | 1,630 | 1,652 | -79 | -4.6% | 1,440,700 |
2025/02/03 | 1,818 | 1,892 | 1,725 | 1,731 | -77 | -4.3% | 1,609,300 |
2025/01/31 | 2,120 | 2,120 | 1,808 | 1,808 | -220 | -10.8% | 2,924,300 |
2025/01/30 | 1,998 | 2,028 | 1,876 | 2,028 | -10 | -0.5% | 2,271,000 |
2025/01/29 | 2,154 | 2,155 | 1,981 | 2,038 | -152 | -6.9% | 2,117,900 |
2025/01/28 | 2,250 | 2,270 | 2,150 | 2,190 | -109 | -4.7% | 1,430,400 |
2025/01/27 | 2,660 | 2,660 | 2,260 | 2,299 | -461 | -16.7% | 2,101,700 |
2025/01/24 | 2,776 | 2,857 | 2,710 | 2,760 | -66 | -2.3% | 559,000 |
2025/01/23 | 3,025 | 3,060 | 2,801 | 2,826 | -174 | -5.8% | 558,600 |
2025/01/22 | 3,035 | 3,100 | 2,868 | 3,000 | +19 | +0.6% | 503,400 |
2025/01/21 | 3,200 | 3,250 | 2,901 | 2,981 | -224 | -7% | 797,000 |
2025/01/20 | 3,405 | 3,415 | 3,090 | 3,205 | -230 | -6.7% | 570,700 |
2025/01/17 | 3,460 | 3,630 | 3,390 | 3,435 | -50 | -1.4% | 367,900 |
51~
100
件表示中 / 213件
類似銘柄と比較する
現在ご覧いただいている「ハートシード」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ハートシード | 375,000円 | +174.2% | - | 0.00% | - | 11.25倍 |
|
慶応大学発ベンチャー。iPS細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
持田薬 | 294,500円 | +5.1% | -7.0% | 2.72% | 19.33倍 | 0.80倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 148,300円 | -2.4% | -52.3% | 3.84% | 17.75倍 | 0.63倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ネクセラファーマ | 91,900円 | +20.3% | - | 0.00% | 162.94倍 | 1.21倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
栄研化 | 215,600円 | +4.1% | -3.1% | 2.69% | 18.78倍 | 1.64倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム